𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A dose escalation study of carboplatin and ifosfamide in advanced ovarian cancer

✍ Scribed by Christopher J. Gallagher; Eve Wiltshaw; Robert E. Coleman; Peter G. Harper

Publisher
Springer
Year
1989
Tongue
English
Weight
395 KB
Volume
24
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Tamoxifen in advanced prostatic carcinom
Tamoxifen in advanced prostatic carcinoma. A dose escalation study
✍ Frank M. Torti; Bert L. Lum; Richard Lo; Fuad Freiha; Linda Shortliffe πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 431 KB πŸ‘ 2 views

Patients with advanced prostatic carcinoma who had received minimal or no prior therapy were treated with tamoxifen citrate in escalating doses from 10 to 50 mg orally twice a day. Twenty-nine courses were evaluated in 17 patients. Entry was limited to patients with measurable sites of disease. Ther

Dose escalation study of tezacitabine in
Dose escalation study of tezacitabine in combination with cisplatin in patients with advanced cancer
✍ Keith T. Flaherty; James P. Stevenson; Maryann Gallagher; Bruce Giantonio; Kenne πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The authors performed a dose escalation study of cisplatin and the novel deoxycytidine analog, tezacitabine, to determine the maximum tolerated dose of the combination. ## METHODS Twenty‐three patients with advanced cancer and good performance status were accrued to 3 d